Global Antifungal infection Therapeutics (Allylamines, Polyenes, Echinocandins and Azoles) Market Analysis & Trends 2016-2025 - Research and Markets

DUBLIN, Feb. 20, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Antifungal infection Therapeutics Market Analysis & Trends - Drug Type (Allylamines, Polyenes, Echinocandins and Azoles) - Forecast to 2025" report to their offering.

This industry report analyzes the global markets for Antifungal infection Therapeutics across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.

Some of the prominent trends that the market is witnessing include huge number of infections are caused by aspergillus and candida fungus, introduction of new drugs, recent technological developments of Antifungal infection Therapeutics and growth opportunities/investment opportunities.

The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

Report Highlights:

- The report provides a detailed analysis on current and future market trends to identify the investment opportunities - Market forecasts till 2025, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2025
- Market opportunities and recommendations for new investments

Key Topics Covered:

1 Market Outline

2 Executive Summary

3 Market Overview
3.1 Current Trends
3.1.1 Huge Number of Infections are Caused by Aspergillus and Candida Fungus
3.1.2 Introduction of New Drugs
3.1.3 Recent Technological Developments of Antifungal infection Therapeutics
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness

4 Antifungal infection Therapeutics Market, By Drug Type
4.1 Allylamines
4.2 Polyenes
4.3 Echinocandins
4..4 Azoles

5 Antifungal infection Therapeutics Market, By Geography 

6 Key Player Activities
6.1 Mergers & Acquisitions
6.2 Partnerships, Joint Venture's, Collaborations and Agreements
6.3 Product Launch & Expansions
6.4 Other Activities

7 Leading Companies
7.1 Novartis
7.2 Gilead
7.3 Asperqillus
7.4 Glaxosmithkline
7.5 Kramer Laboratories
7.6 Alternaria
7.7 Sanofi-Aventis
7.8 Pfizer
7.9 Enzon Pharmaceuticals
7.10 Abbott Laboratories
7.11 SCYNEXIS Inc.
7.12 Bayer Healthcare
7.13 Merck & Co.
7.14 Astellas Pharma Inc.

For more information about this report visit http://www.researchandmarkets.com/research/vjh6w2/global_antifungal

Media Contact:

Laura Wood, Senior Manager
[e-mail]

For E.S.T Office Hours Call [phone]
For U.S./CAN Toll Free Call [phone]
For GMT Office Hours Call [phone]

U.S. Fax: [phone]
Fax (outside U.S.): [phone]